NCT01552863View on ClinicalTrials.gov

A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Pain
Interventions
DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation A, single dose

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation E, single dose

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation F, single dose

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation G, single dose

DRUG

Oxycodone

One capsule of 5 mg PF-00345439 Formulation TBD, single dose

DRUG

Oxycodone

One capsule of 40 mg PF-00345439 Formulation H, single dose

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pain Therapeutics
All Listed Sponsors
lead

Pain Therapeutics

INDUSTRY